With age, the meniscus receives less and less blood—with the inner most area becoming avascular. Tears in this area do not heal normally, often requiring surgery. Surgeons can draw fibrin, a protein involved in blood clotting, from peripheral blood (PB) or bone marrow aspirate (BMA), and implant a fibrin blood clot into the injured area to help with healing.
Use of a biodegradable balloon spacer during massive rotator cuff tear surgery produced similar outcomes when compared to partial rotator cuff repair for patients with massive rotator cuff tears (MRCTs) at 24-month follow up, with potential for early improvement.
Every athlete wants an answer to the million-dollar question: “How can I avoid tearing my ACL?” “Proper form can help athletes avoid this serious injury,” says orthopaedic surgeon.
Outcomes of revision anterior cruciate ligament (ACL) reconstruction are known to be inferior to those of primary procedures, but little has been known about why this occurs – until now. New research from Washington University, St. Louis, Missouri, and Vanderbilt University Medical Center, Nashville, Tennessee, suggests that 2 important clinical decisions can significantly improve a patient’s chances of a experiencing a good outcome after revision surgery.
A Head-to-Head Evaluation of Subacromial Balloon Spacer vs. Partial Repair for Massive Rotator Cuff Tears
Although various treatment options are available, successfully managing patients with massive rotator cuff tears remains a challenge. One option that has generated considerable interest among orthopaedic surgeons is implantation of a biodegradable subacromial balloon spacer that has the potential to recenter the humeral head within the glenoid.